Influence of anatomic location on prognosis of malignant melanoma: Attempt to verify the BANS model

Gary S. Rogers; Alfred W. Kopf; Darrell S. Rigel; Marcia L. Levenstein; Robert J. Friedman; Matthew N. Harris; Frederick M. Golomb; Patrick Hennessey; Stephen L. Gumport; Daniel F. Roses; Medwin M. Mintzis

doi:10.1016/S0190-9622(86)70162-X

Influence of anatomic location on prognosis of malignant melanoma: Attempt to verify the BANS model

Gary S. Rogers, Alfred W. Kopf, Darrell S. Rigel, Marcia L. Levenstein, Robert J. Friedman, Matthew N. Harris, Frederick M. Golomb, Patrick Hennessey, Stephen L. Gumport, Daniel F. Roses, Medwin M. Mintzis

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Abstract

Stage I cutaneous malignant melanomas between 0.76 and 1.69 mm thick (Breslow measurement) in BANS (upper part of the back, posterior aspects of the arms, posterior and lateral aspects of the neck, posterior aspect of the scalp) areas have been reported to portend a relatively poor prognosis compared to non-BANS sites. We were unable to confirm the 15% poorer survival for BANS area lesions (84% BANS, 99% non-BANS) originally reported. In this report of 211 patients, malignant melanomas in BANS sites had a 4.6% poorer 5-year cumulative survival rate (88.9% BANS, 93.5% non-BANS; p = 0.35). Although many more patients need to be studied, we believe this small difference in survival is insufficient to influence therapeutic management strategies.

Original language	English
Pages (from-to)	231-237
Number of pages	7
Journal	Journal of the American Academy of Dermatology
Volume	15
Issue number	2
DOIs	https://doi.org/10.1016/S0190-9622(86)70162-X
State	Published - 1986
Externally published	Yes

Keywords

BANS
High-risk sites for malignant melanoma metastases (upper part of the back, posterior aspects of the arms, posterior and lateral aspects of the neck, posterior aspect of the scalp)
MCG
MGH
MMCCG
Malignant Melanoma Clinical Cooperative Group (NYU + MGH)
Massachusetts General Hospital
Melanoma Cooperative Group (NYU only)
NYU
New York University Medical Center

Access to Document

10.1016/S0190-9622(86)70162-X

Cite this

Rogers, G. S., Kopf, A. W., Rigel, D. S., Levenstein, M. L., Friedman, R. J., Harris, M. N., Golomb, F. M., Hennessey, P., Gumport, S. L., Roses, D. F., & Mintzis, M. M. (1986). Influence of anatomic location on prognosis of malignant melanoma: Attempt to verify the BANS model. Journal of the American Academy of Dermatology, 15(2), 231-237. https://doi.org/10.1016/S0190-9622(86)70162-X

@article{b52dc2beef1f4e53b0fe27b5e3112d6f,

title = "Influence of anatomic location on prognosis of malignant melanoma: Attempt to verify the BANS model",

abstract = "Stage I cutaneous malignant melanomas between 0.76 and 1.69 mm thick (Breslow measurement) in BANS (upper part of the back, posterior aspects of the arms, posterior and lateral aspects of the neck, posterior aspect of the scalp) areas have been reported to portend a relatively poor prognosis compared to non-BANS sites. We were unable to confirm the 15% poorer survival for BANS area lesions (84% BANS, 99% non-BANS) originally reported. In this report of 211 patients, malignant melanomas in BANS sites had a 4.6% poorer 5-year cumulative survival rate (88.9% BANS, 93.5% non-BANS; p = 0.35). Although many more patients need to be studied, we believe this small difference in survival is insufficient to influence therapeutic management strategies.",

keywords = "BANS, High-risk sites for malignant melanoma metastases (upper part of the back, posterior aspects of the arms, posterior and lateral aspects of the neck, posterior aspect of the scalp), MCG, MGH, MMCCG, Malignant Melanoma Clinical Cooperative Group (NYU + MGH), Massachusetts General Hospital, Melanoma Cooperative Group (NYU only), NYU, New York University Medical Center",

author = "Rogers, {Gary S.} and Kopf, {Alfred W.} and Rigel, {Darrell S.} and Levenstein, {Marcia L.} and Friedman, {Robert J.} and Harris, {Matthew N.} and Golomb, {Frederick M.} and Patrick Hennessey and Gumport, {Stephen L.} and Roses, {Daniel F.} and Mintzis, {Medwin M.}",

year = "1986",

doi = "10.1016/S0190-9622(86)70162-X",

language = "English",

volume = "15",

pages = "231--237",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Mosby Inc.",

number = "2",

}

TY - JOUR

T1 - Influence of anatomic location on prognosis of malignant melanoma

T2 - Attempt to verify the BANS model

AU - Rogers, Gary S.

AU - Kopf, Alfred W.

AU - Rigel, Darrell S.

AU - Levenstein, Marcia L.

AU - Friedman, Robert J.

AU - Harris, Matthew N.

AU - Golomb, Frederick M.

AU - Hennessey, Patrick

AU - Gumport, Stephen L.

AU - Roses, Daniel F.

AU - Mintzis, Medwin M.

PY - 1986

Y1 - 1986

N2 - Stage I cutaneous malignant melanomas between 0.76 and 1.69 mm thick (Breslow measurement) in BANS (upper part of the back, posterior aspects of the arms, posterior and lateral aspects of the neck, posterior aspect of the scalp) areas have been reported to portend a relatively poor prognosis compared to non-BANS sites. We were unable to confirm the 15% poorer survival for BANS area lesions (84% BANS, 99% non-BANS) originally reported. In this report of 211 patients, malignant melanomas in BANS sites had a 4.6% poorer 5-year cumulative survival rate (88.9% BANS, 93.5% non-BANS; p = 0.35). Although many more patients need to be studied, we believe this small difference in survival is insufficient to influence therapeutic management strategies.

AB - Stage I cutaneous malignant melanomas between 0.76 and 1.69 mm thick (Breslow measurement) in BANS (upper part of the back, posterior aspects of the arms, posterior and lateral aspects of the neck, posterior aspect of the scalp) areas have been reported to portend a relatively poor prognosis compared to non-BANS sites. We were unable to confirm the 15% poorer survival for BANS area lesions (84% BANS, 99% non-BANS) originally reported. In this report of 211 patients, malignant melanomas in BANS sites had a 4.6% poorer 5-year cumulative survival rate (88.9% BANS, 93.5% non-BANS; p = 0.35). Although many more patients need to be studied, we believe this small difference in survival is insufficient to influence therapeutic management strategies.

KW - BANS

KW - High-risk sites for malignant melanoma metastases (upper part of the back, posterior aspects of the arms, posterior and lateral aspects of the neck, posterior aspect of the scalp)

KW - MCG

KW - MGH

KW - MMCCG

KW - Malignant Melanoma Clinical Cooperative Group (NYU + MGH)

KW - Massachusetts General Hospital

KW - Melanoma Cooperative Group (NYU only)

KW - NYU

KW - New York University Medical Center

UR - http://www.scopus.com/inward/record.url?scp=0022499470&partnerID=8YFLogxK

U2 - 10.1016/S0190-9622(86)70162-X

DO - 10.1016/S0190-9622(86)70162-X

M3 - Article

C2 - 3745528

AN - SCOPUS:0022499470

SN - 0190-9622

VL - 15

SP - 231

EP - 237

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 2

ER -

Influence of anatomic location on prognosis of malignant melanoma: Attempt to verify the BANS model

Abstract

Keywords

Access to Document

Fingerprint

Cite this